LGALS3 and hydrops fetalis: Moreover, the pooled analysis of three clinical trials including 902 HF patients [26] demonstrated that HF patients with galectin-3 > 17.6 pg/mL had a greater risk (2.6–3 times) of being readmitted for ADHF from 30 to 120 days after discharge.